Immunocore Holdings PLC expected to post a loss of 37 cents a share - Earnings Preview
06/05/2024 08:32
* Immunocore Holdings PLC IMCR.OQ IMCR.O is expected
to show a
rise in quarterly revenue when it reports results on May 8
(estimated) for the period ending January 1 0001
* The Abingdon Oxfordshire-based company is expected to
report a
31.9% increase in revenue to $71.383 million from $54.12 million
a year ago, according to the mean estimate from 16 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Immunocore Holdings PLC
is for
a loss of 37 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.
* Wall Street's median 12-month price target for Immunocore
Holdings PLC is $89.50, above its last closing price
of $60.23.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.28 -0.28 -0.40 Missed -47
Sep. 30 2023 -0.35 -0.35 0.05 Beat 113.8
Jan. 1 0001 -0.40 -0.41 -0.36 Beat 9.7
Mar. 31 2023 -0.45 -0.39 -0.43 Missed -10.7
Dec. -0.01 0.00 -0.63 Missed -2,523
31 2022 ,264.5
Sep. 30 2022 -0.25 -0.32 0.14 Beat 141.7
Jun. 30 2022 -0.72 -0.82 -0.18 Beat 79.1
Mar. 31 2022 -1.04 -1.07 -0.50 Beat 56.2
This summary was machine generated May 6 at 07:32 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)